跳至主要内容
临床试验/DRKS00014917
DRKS00014917已完成不适用

ong-term results after surgical repair of atrioventricular septal defect

DHZB0 个研究点目标入组 508 人开始时间: 2018年7月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
508

研究概览

简要总结

In-hospital mortality decreased from 10.2% (n = 26) in early surgical era to 1.6% (n = 4) in late surgical era (P < 0.001). Seventy-seven patients required reoperation. Freedom from reoperation was 84.4% after 25 years. The main indication for reoperation was left atrioventricular valve regurgitation (13.8%). The multivariable Cox regression analysis revealed reoperation of the left AV valve, early surgical era, patient age <3.0 months and complex AVSD to be independent risk factors for mortality. Age <3.0 months, complex AVSD and moderate/severe left AV valve regurgitation at discharge predicted reoperation.

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • Patients who received surgical repair of atrioventricular septal defect at DHZB between 1988 and 2017.

排除标准

  • Patients who did not receive surgical repair of atrioventricular septal defect at DHZB.

研究者

发起方
DHZB

相似试验